<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="in-brief" dtd-version="2.3" xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">SCIENCE</journal-id>
<journal-title>Science</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Science</abbrev-journal-title>
<issn pub-type="ppub">0036-8075</issn>
<issn pub-type="epub">1095-9203</issn>
<publisher>
<publisher-name>American Association for the Advancement of Science</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-categories>
<subj-group subj-group-type="article-type"><subject>This Week in Science</subject></subj-group>
<subj-group subj-group-type="heading"><subject>This Week in Science</subject></subj-group>
<subj-group subj-group-type="legacy-article-type"><subject>twis</subject></subj-group>
<subj-group subj-group-type="field"><subject>IMMUNOLOGY</subject></subj-group>
<subj-group subj-group-type="display-ad"><subject>Virology</subject><subject>Immunology</subject></subj-group>
</article-categories>
<title-group>
<article-title>INTERFER(ON)ing Persistence</article-title>
</title-group>
<pub-date pub-type="ppub">
<day>12</day>
<month>04</month>
<year>2013</year>
</pub-date>
<volume>340</volume>
<issue>6129</issue>
<fpage seq="k">117</fpage>
<lpage>117</lpage>
<permissions>
<copyright-statement>Copyright &#x00A9; 2013, American Association for the Advancement of Science</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder>American Association for the Advancement of Science</copyright-holder>
</permissions>
<self-uri xlink:title="pdf" xlink:href="twis.pdf" />
<custom-meta-wrap>
<custom-meta><meta-name>Editor</meta-name><meta-value>Caroline Ash</meta-value></custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<fig id="F1" position="anchor">
<graphic xlink:href="340_117k_F1"></graphic>
<attrib>CREDIT: TEIJARO <italic>ET AL.</italic></attrib>
</fig>
<p>During persistent viral infections, a dysregulated immune response fails to control the infection. <bold>Wilson <italic>et al.</italic></bold> (p. <related-article related-article-type="in-this-issue" vol="340" issue="6129" page="202">202</related-article>) and <bold>Teijaro <italic>et al.</italic></bold> (p. <related-article related-article-type="in-this-issue" vol="340" issue="6129" page="207">207</related-article>; see the Perspective by <bold><related-article related-article-type="in-this-issue" vol="340" page="155" issue="6129">Odorizzi and Wherry</related-article></bold>) show this occurs because type I interferons (IFN I), critical for early responses to viral infection, contribute to the altered immunity seen during persistent infection. Antibody blockade of IFN I signaling during chronic lymphocytic choriomeningitis virus (LCMV) in mice resulted in reduced viral titers at later stages of infection, reduced expression of inhibitory immune molecules and prevented the disruptions to secondary lymphoid organs typically observed during persistent infection with LCMV. Whether type I IFNs are also detrimental to persistent viral infection humans, such as HIV and hepatitis C virus, remains to be determined.</p>
</body>
</article>